Brief: Pds Biotechnology Corp - Plans To Initiate Versatile-003 Phase 3 Clinical Trial In Late 2023
18/05/2023 22:30
PDS Biotechnology Corp PDSB.O :
* PDS BIOTECHNOLOGY CORP - PLANS TO INITIATE VERSATILE-003
PHASE 3
CLINICAL TRIAL IN LATE 2023
Source text for Eikon: ID:
Further company coverage: PDSB.O
Recent news on PDS Biotechnology
See all newsPDS Biotechnology Corp reports results for the quarter ended September 30 - Earnings Summary
PDS Biotechnology Q3 net loss narrows on lower R&D costs
PDS Biotechnology Corp expected to post a loss of 10 cents a share - Earnings Preview
Brief: PDS Biotech Announces Initial Closing Of Up To $22.3 Mln PIPE Financing
Brief: Pds Biotechnology Corp - On Aug 6, Approved Reduction In Force To Align Expenses With Strategic Priorities - SEC Filing